Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Influenza Hemagglutinin (HA) Peptide: Precision Tag for P...

    2026-02-11

    Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Detection and Purification

    Executive Summary: Influenza Hemagglutinin (HA) Peptide is a synthetic nine-amino acid tag (YPYDVPDYA) derived from influenza virus hemagglutinin, extensively validated for use in molecular biology as an epitope tag (Wei et al., 2021, DOI). The peptide enables specific and reversible capture or elution of HA-tagged fusion proteins via competitive binding to high-affinity anti-HA antibodies (APExBIO A6004). Solubility exceeds 55.1 mg/mL in DMSO, 100.4 mg/mL in ethanol, and 46.2 mg/mL in water, supporting diverse experimental conditions. Purity >98% is confirmed by HPLC/mass spectrometry, ensuring reproducible results. The HA tag peptide is a validated tool for immunoprecipitation, protein purification, and protein-protein interaction studies in both basic and translational research (Pex-EGFP.com).

    Biological Rationale

    The Influenza Hemagglutinin (HA) Peptide is derived from the HA protein of the human influenza virus, a surface glycoprotein essential for viral entry into host cells (Wei et al., 2021). The nine-amino acid sequence YPYDVPDYA corresponds to a highly immunogenic epitope recognized by monoclonal anti-HA antibodies. This sequence is widely used to tag recombinant proteins, facilitating detection, purification, and functional assessment without significantly altering the biochemical properties of the fusion partner (APExBIO).

    HA tag technology is a cornerstone in molecular biology, enabling researchers to interrogate protein-protein interactions, map protein trafficking, and study post-translational modifications. Unlike endogenous tags, HA tags are minimally immunogenic in most model organisms, reducing background signal. The peptide tag’s small size (1.1 kDa) and hydrophilicity further minimize steric hindrance and aggregation, making it highly adaptable for protein engineering (related article—this article provides updated evidence for purity and workflow integration).

    Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

    The HA tag peptide operates as a competitive ligand for anti-HA antibodies. During immunoprecipitation, HA-tagged proteins are captured by anti-HA antibodies immobilized on beads or resin. Addition of excess free HA peptide displaces the HA-tagged protein by occupying the antibody’s antigen-binding site, resulting in specific elution (Cell Research).

    This elution mechanism is reversible and non-denaturing, preserving protein structure and activity for downstream analysis. The specificity of the antibody-peptide interaction ensures that only HA-tagged proteins are released, enabling high-purity isolation. The HA peptide’s high solubility in DMSO, ethanol, and water facilitates rapid exchange during elution steps.

    Recent studies in exosome biology and protein trafficking highlight the value of competitive elution for isolating multiprotein complexes and vesicle-associated proteins (Next-Generation Strategies—this article details new benchmarks for exosome workflow integration, extending previous reports).

    Evidence & Benchmarks

    • HA tag sequence (YPYDVPDYA) is specifically and reproducibly recognized by monoclonal anti-HA antibodies (Wei et al., 2021, DOI).
    • Pepide solubility is ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at room temperature (APExBIO, product data).
    • Purity >98% is confirmed by HPLC and mass spectrometry (APExBIO, product page).
    • Competitive elution with 1 mg/mL HA peptide preserves native protein conformation and complex assembly in immunoprecipitation workflows (Wei et al., 2021, DOI).
    • HA tag is compatible with both mammalian and yeast expression systems, with minimal interference in protein folding or localization (Pex-EGFP.com).
    • Validated use in isolating exosome-associated proteins and mapping endosomal sorting pathways (Wei et al., 2021, DOI).

    Applications, Limits & Misconceptions

    The Influenza Hemagglutinin (HA) Peptide is widely used in:

    • Immunoprecipitation (IP) and co-immunoprecipitation (co-IP) of HA-tagged proteins.
    • Affinity purification of recombinant proteins via competitive elution.
    • Protein-protein interaction studies in cell lysates and purified systems.
    • Detection in Western blot, ELISA, and immunofluorescence assays.
    • Mapping vesicle and exosome-associated protein cargo (Redefining Translational Protein Science—this article synthesizes mechanistic and clinical advances, complementing the present technical focus).

    Common Pitfalls or Misconceptions

    • HA peptide is not suitable for eluting non-HA-tagged proteins; specificity is conferred by tag-antibody interaction.
    • Prolonged storage of peptide solutions (even at -20°C) can cause degradation; always prepare fresh solutions.
    • High peptide concentrations may interfere with downstream mass spectrometry unless removed post-elution.
    • HA tag does not enhance solubility or expression yield of the fused protein; it is a detection/purification tag only.
    • Not all anti-HA antibodies have identical affinity; performance may vary by clone and vendor.

    Workflow Integration & Parameters

    For optimal use, the HA peptide (APExBIO A6004) should be dissolved in DMSO, ethanol, or water at the desired working concentration (≥1 mg/mL typical for IP elution). Store lyophilized peptide desiccated at -20°C; avoid repeated freeze-thaw cycles. In immunoprecipitation, add the peptide to the antibody-resin complex after protein capture, incubate for 10–30 minutes at 4°C, and collect the eluate (product protocol).

    Compatibility has been demonstrated with a wide range of anti-HA antibody clones and magnetic bead formats. The HA peptide is also validated for use in exosome isolation workflows, including those targeting ESCRT-independent pathways (Wei et al., 2021).

    For advanced applications (e.g., mapping E3 ligase substrates or signaling complexes), consult recent mechanistic reviews (Redefining Protein Interaction Discovery—this article focuses on E3 ligase and ubiquitination workflows, whereas the current review emphasizes peptide biochemistry and competitive binding parameters).

    Conclusion & Outlook

    The Influenza Hemagglutinin (HA) Peptide, as supplied by APExBIO (A6004), remains a gold standard for epitope tagging in molecular and cell biology. Its high purity, robust solubility, and reproducibility underpin its widespread adoption in protein detection, purification, and interaction studies. Ongoing advances in exosome biology and protein trafficking underscore the continued relevance of the HA tag for precision research. As next-generation molecular workflows emerge, the HA peptide will remain central to high-specificity, high-throughput protein analysis and translational research.